PHARMACY

Eli Lilly and Co.’s Trulicity now available

BY Ryan Chavis

INDIANAPOLIS — Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said. Trulicity received approval from the Food and Drug Administration in September. 
 
“Some adults with Type 2 diabetes find that diet, exercise and oral medicines aren’t enough to meet their treatment goals,” said Dr. Laura Fernandez, senior medical advisor, Lilly Diabetes. “Trulicity may be an option for them as it has demonstrated proven glycemic control, only has to be taken once weekly, and comes in an easy-to-use pen.”
 
Trulicity is meant to be used as an adjunct to diet and exercise to improve glycemic control in adults who have Type 2 diabets. It is not recommended as a first-line therapy for patients who aren't adequately controlled on diet and exercise, the company said. Trulicity also is not indicated for the treatment of Type 1 diabetes or diabetic ketoacidosis.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Rite Aid launches Vaccine Central to promote vaccinations

BY Michael Johnsen

 

CAMP HILL, Pa. — A national survey from Rite Aid and National Foundation for Infectious Diseases released Monday found that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases. 
 
“At a time when vaccine-preventable diseases like flu, shingles, whooping cough and measles are highly visible in the media around the country, this survey supports what we as community pharmacists already knew — that there is clearly a need to educate consumers and raise awareness about the importance of vaccinations,” said Robert Thompson, Rite Aid EVP pharmacy. 
 
The survey also found that 79% of women reported they would find an immunization evaluation from a pharmacy helpful. In response, Rite Aid is announcing the launch of Vaccine Central, a multifaceted online platform designed to help raise awareness about vaccines and promote vaccinations. Rite Aid pharmacists, all of whom are certified immunizers, will be available to consult with customers and answer any vaccination questions.
 
“Education and prevention are central to the NFID mission,” noted Marla Dalton, NFID executive director. “According to the Centers for Disease Control and Prevention, up to 50,000 adults die from vaccine-preventable diseases in the U.S. every year. It is important for adults to understand which vaccines are recommended for them and when. Any tool that helps consumers in this process is a valuable asset to public health.” 
 
At Rite Aid’s Vaccine Central, www.riteaid.com/vaccinecentral, visitors can complete an immunization evaluation, track their personal immunization history and find other educational resources on immunizations. 
 
“Our new immunization assessment tool puts important resources like vaccine recommendations, information about vaccine-preventable diseases and immunization records right at the fingertips of consumers, helping them to make important healthcare decisions for themselves and their families, now and in the future,” Thompson said. 
 
According to a telephone survey of 1,000 randomly selected U.S. adult women ages 26 years to 74 years, 70% of survey participants reported receiving at least one vaccination in the last five years to prevent disease — most often citing the flu and tetanus vaccines. When asked about a range of other common vaccines, some of which are recommended only for targeted age groups, most respondents reported they were not up to date. 
 
The survey also indicated that 60% of women intended to receive a vaccination in the next five years. The vaccine-preventable diseases women saw as the most serious threats to their health included influenza/flu (44%), pneumonia (26%) and shingles (20%). 
 
Although more than 2-in-5 women viewed flu as a serious threat to their health in the next five years, the survey showed that 49% do not intend to get a flu vaccine in that same time frame, indicating that perceived risk does not necessarily align with vaccination behavior.  
 
Other notable findings from the Rite Aid and NFID survey include:
 
  • More than 25% of U.S. women who reported receiving a flu vaccine in the past year did so at a drug store;
  • Approximately 3-in-10 women (29%) consult their pharmacists about infectious diseases, vaccines and immunizations; and
  • The misconception that a flu shot causes the flu was the leading response (28%) as to why survey participants did not receive the vaccine.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

M.BAUMGARDT says:
Dec-10-2015 09:04 am

Great post

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

NACDS names manager, pharmacy care

BY Antoinette Alexander

 

ARLINGTON, Va. — The National Association of Chain Drug Stores has bolstered its pharmacy care and patient advocacy department with the hiring of Sara Rubin, who has joined NACDS as manager, pharmacy care. Rubin reports to Alex Adams, VP, pharmacy programs. 

In her new role, Rubin will be responsible for providing support for the development and implementation of select NACDS pharmacy care initiatives. Among her duties, Rubin will provide analysis of emerging health issues, such as accountable care organizations and medical homes, as they relate to pharmacy care. She will also develop and implement educational and training programming for NACDS meetings, as well as manage and oversee activities related to NACDS’ work with colleges and universities of pharmacy.

“We are pleased to welcome Sara to the NACDS team,” stated NACDS president and CEO Steve Anderson. “As pharmacy’s role in healthcare delivery continues to evolve, Sara’s background in public health at the federal and state level will serve her well in advancing NACDS’ pharmacy care initiatives on behalf of the industry.”

Previously, Rubin served as a senior program analyst for the National Association of County and City Health Officials in Washington, DC, leading efforts to connect public health departments with community pharmacies.  Among other prior positions, Rubin also served as project manager for the Florida Division of Emergency Management in Tallahassee, Fla.

Rubin also co-founded and moderates the first and ongoing Twitter chat about public health, Public Health Talks (@PubHealthTalks/#PubHT), which has nearly 1,700 followers. 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?